Teva Pharmaceutical Industries Limited (TEVA)
-NYSE | Prev Close: | 39.64 |
|---|
| Open: | N/A |
|---|
| Bid: | 39.14 x 500 |
|---|
| Ask: | 39.80 x 1500 |
|---|
| 1y Target Est: | 44.60 |
|---|
| Beta: | 0.76 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 36.63 - 42.83 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 3,833,070 |
|---|
| Market Cap: | 33.77B |
|---|
| P/E (ttm): | 19.79 |
|---|
| EPS (ttm): | 2.00 |
|---|
| Div & Yield: | 1.09 (2.80%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & Moreat CNBC(Wed, 04:43 SGT)
- Teva to Acquire MicroDose TherapeutxZacks(Tue, 18 Jun)
- Supreme Court decision on generics hits Actavis, but few other drug firmsat MarketWatch(Tue, 18 Jun)
- Teva Pharma buying MicroDose Therapeutx for $40MAP(Tue, 18 Jun)
- Teva Pharma buying MicroDose Therapeutx for $40MAP(Tue, 18 Jun)
- Supreme Court rules generic drug makers can be sued over 'pay to delay'at theflyonthewall.com(Tue, 18 Jun)
- Teva Adds MicroDose to Respiratory Business in $165 Million Dealat Bloomberg(Mon, 17 Jun)
- News Summary: $2.15B settlement in Protonix caseAP(Thu, 13 Jun)
- Pfizer settles Protonix patent case for $2.15BAP(Wed, 12 Jun)
- Momenta Pharma rises following upgrade from UBSAP(Fri, 7 Jun)
- OncoGenex' Candidate ProgressesZacks(Fri, 15 Feb)
- Teva Enrolls First Patient in StudyZacks(Wed, 13 Feb)
- Teva Misses, Hikes DividendZacks(Fri, 8 Feb)
- Company News for February 08, 2013Zacks(Fri, 8 Feb)
- Teva Ends CureTech CollaborationZacks(Tue, 5 Feb)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| TEVA | 0.00% | 33.77B |
| NVO | 0.00% | 87.67B |
| AGN | 0.00% | 30.08B |
| FRX | 0.00% | 11.09B |
Key Statistics
| Forward P/E (1 yr): | 7.26 |
|---|
| P/S (ttm): | 1.68 |
|---|
| Ex-Dividend Date: | 16-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.20 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.11 |
|---|
Business Summary
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as ste...
View More 
0.45%